BK vs BMY · P/E 17, $94.14B cap vs P/E 17, rev $24.46B
The Bank of New York Mellon Corporation (BK) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
BK does not have a complete income-statement cache yet.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BK currently screens at market cap $94.14B and trailing P/E 17.0. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the BK and BMY stock pages for the full models.
Not investment advice.